Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2003-12

AUTHORS

I. Fogelman, G. M. Blake, R. Blamey, M. Palmer, W. Sauerbrei, M. Schumacher, D. Serin, A. Stewart, W. Wilpshaar

ABSTRACT

The purpose of this study was to compare changes in bone mineral density (BMD) in premenopausal patients with node-positive early breast cancer treated with goserelin (Zoladex) or cyclophosphamide, methotrexate and 5-fluorouracil (CMF). Patients ( n=1640) were randomized to goserelin (3.6 mg every 28 days for 2 years) or CMF (sixx28-day cycles) treatment. In a protocoled sub-study involving 96 patients from eight centers (goserelin: n=53; CMF: n=43), lumbar spine (L2-L4) and femoral neck BMD were assessed by dual X-ray absorptiometry at baseline and then annually for 3 years. At the end of the 2-year goserelin-treatment period, mean BMD losses for goserelin-treated and CMF-treated patients were -10.5% and -6.5% ( P=0.0005) for lumbar spine and -6.4% and -4.5% ( P=0.04) for femoral neck, respectively. At 3 years, partial recovery of BMD was observed in goserelin recipients. In contrast, mean BMD losses for the CMF group indicated persistent BMD loss. No significant differences in BMD were observed between groups at the 3-year assessment of the spine or femoral neck. In the CMF group, based on amenorrhea status at 48 weeks, BMD losses at the lumbar spine were greater for amenorrheic than non-amenorrheic patients. Ovarian suppression resulting in amenorrhea was closely related to BMD loss in both treatment groups. Overall, patients who received CMF did not show recovery of BMD throughout follow-up, whereas partial recovery was observed 1 year after cessation of goserelin therapy, associated with the return of ovarian function in the majority of patients. More... »

PAGES

1001-1006

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00198-003-1508-y

DOI

http://dx.doi.org/10.1007/s00198-003-1508-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1044150768

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/14530912


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Amenorrhea", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Agents, Hormonal", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Bone Density", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cyclophosphamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Drug Administration Schedule", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Femur Neck", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Fluorouracil", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Goserelin", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lumbar Vertebrae", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Methotrexate", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Premenopause", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "name": [
            "Department of Nuclear Medicine, Guy\u2019s, Kings and St Thomas\u2019 Hospital Medical School, SE1 9RT, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Fogelman", 
        "givenName": "I.", 
        "id": "sg:person.0655217537.21", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655217537.21"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Department of Nuclear Medicine, Guy\u2019s, Kings and St Thomas\u2019 Hospital Medical School, SE1 9RT, London, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Blake", 
        "givenName": "G. M.", 
        "id": "sg:person.01102033437.11", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102033437.11"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Nottingham Hospital, Nottingham, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Blamey", 
        "givenName": "R.", 
        "id": "sg:person.015650304144.58", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015650304144.58"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AstraZeneca (United Kingdom)", 
          "id": "https://www.grid.ac/institutes/grid.417815.e", 
          "name": [
            "AstraZeneca, Macclesfield, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Palmer", 
        "givenName": "M.", 
        "id": "sg:person.0705212163.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0705212163.54"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Sauerbrei", 
        "givenName": "W.", 
        "id": "sg:person.01026070224.70", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026070224.70"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Institute fur Medizinische Biometrie und Informatik, University Hospital, Freiburg, Germany"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Schumacher", 
        "givenName": "M.", 
        "id": "sg:person.0646232763.44", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646232763.44"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Clinic Sainte Catherine, Avignon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Serin", 
        "givenName": "D.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "The Christie Hospital", 
          "id": "https://www.grid.ac/institutes/grid.415720.5", 
          "name": [
            "Christie Hospital, Manchester, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Stewart", 
        "givenName": "A.", 
        "id": "sg:person.0647367524.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647367524.01"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AstraZeneca (United Kingdom)", 
          "id": "https://www.grid.ac/institutes/grid.417815.e", 
          "name": [
            "AstraZeneca, Macclesfield, UK"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Wilpshaar", 
        "givenName": "W.", 
        "id": "sg:person.01021440563.37", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021440563.37"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1023/a:1005792830054", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003671030", 
          "https://doi.org/10.1023/a:1005792830054"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1067/mgn.2001.113534", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005950645"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(01)80148-9", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006522013"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0015-0282(16)58200-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007157689"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(97)10135-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012452075"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s001980070062", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012689352", 
          "https://doi.org/10.1007/s001980070062"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1990.58", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015146238", 
          "https://doi.org/10.1038/bjc.1990.58"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1990.58", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015146238", 
          "https://doi.org/10.1038/bjc.1990.58"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jbmr.5650091002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017261313"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jbmr.5650091002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017261313"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/jnci/90.9.704", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018904729"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/07357909809039747", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019046058"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0959-8049(97)10036-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019758885"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02555894", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020486492", 
          "https://doi.org/10.1007/bf02555894"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf02555894", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1020486492", 
          "https://doi.org/10.1007/bf02555894"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1359/jbmr.1997.12.1.16", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1021846486"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm197602192940801", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022455515"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0140-6736(93)92555-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027878716"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0140-6736(93)92555-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027878716"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/00016349609033310", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032765154"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0015-0282(16)54948-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037961107"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jbmr.5650101022", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053074833"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/jbmr.5650101022", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053074833"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2002.05.042", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064202982"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2002.09.112", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064203132"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2000.18.14.2718", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1074667563"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1082997667", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.1997.15.4.1341", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083105853"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2003-12", 
    "datePublishedReg": "2003-12-01", 
    "description": "The purpose of this study was to compare changes in bone mineral density (BMD) in premenopausal patients with node-positive early breast cancer treated with goserelin (Zoladex) or cyclophosphamide, methotrexate and 5-fluorouracil (CMF). Patients ( n=1640) were randomized to goserelin (3.6 mg every 28 days for 2 years) or CMF (sixx28-day cycles) treatment. In a protocoled sub-study involving 96 patients from eight centers (goserelin: n=53; CMF: n=43), lumbar spine (L2-L4) and femoral neck BMD were assessed by dual X-ray absorptiometry at baseline and then annually for 3 years. At the end of the 2-year goserelin-treatment period, mean BMD losses for goserelin-treated and CMF-treated patients were -10.5% and -6.5% ( P=0.0005) for lumbar spine and -6.4% and -4.5% ( P=0.04) for femoral neck, respectively. At 3 years, partial recovery of BMD was observed in goserelin recipients. In contrast, mean BMD losses for the CMF group indicated persistent BMD loss. No significant differences in BMD were observed between groups at the 3-year assessment of the spine or femoral neck. In the CMF group, based on amenorrhea status at 48 weeks, BMD losses at the lumbar spine were greater for amenorrheic than non-amenorrheic patients. Ovarian suppression resulting in amenorrhea was closely related to BMD loss in both treatment groups. Overall, patients who received CMF did not show recovery of BMD throughout follow-up, whereas partial recovery was observed 1 year after cessation of goserelin therapy, associated with the return of ovarian function in the majority of patients.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00198-003-1508-y", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1100834", 
        "issn": [
          "0937-941X", 
          "1433-2965"
        ], 
        "name": "Osteoporosis International", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "12", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "14"
      }
    ], 
    "name": "Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF)", 
    "pagination": "1001-1006", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "d24e03ee1a1b3acf8c4c49d9c883c9a523b10d2e69a61c23255507aee2ebe21e"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "14530912"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9100105"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00198-003-1508-y"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1044150768"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00198-003-1508-y", 
      "https://app.dimensions.ai/details/publication/pub.1044150768"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T14:04", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8660_00000490.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1007/s00198-003-1508-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00198-003-1508-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00198-003-1508-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00198-003-1508-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00198-003-1508-y'


 

This table displays all metadata directly associated to this object as RDF triples.

272 TRIPLES      21 PREDICATES      68 URIs      37 LITERALS      25 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00198-003-1508-y schema:about N09e77b26d1624861b40a9f0929a8bb9b
2 N1289d3b6946044a8afabd0a9d7867e0e
3 N1fd4c84b2c2d482c8d68cb9bc656dd76
4 N34977b6ec606481da6485f552ec1a411
5 N45f476f744164f41978045d506928a99
6 N61e257e5026b46c49b493335d043fd10
7 N729f1bf2afdc4a17ac56b8288129a35e
8 N79406c9bef7a4c6aa078a89f9262bc8f
9 Na8e95a1886684a459294b0d7c7da4731
10 Nba0b915563df43a3ac5aad042c061d84
11 Nc9b11d36ca584e8bac95b86d3dbc4c04
12 Nd0f6bc6dd948477a801e9a5f28ebec7c
13 Nda8e7a1db26341149022da9d19da6925
14 Ndfed191195a240c6a2312a9fd60117ac
15 Ne4baf7b9a965484c80d101effdf7c85a
16 Ne66810de7ea44221bfed6b5e201b9c9d
17 anzsrc-for:11
18 anzsrc-for:1103
19 schema:author N1f4d19be1fcc47e1a9f9daeafdae1459
20 schema:citation sg:pub.10.1007/bf02555894
21 sg:pub.10.1007/s001980070062
22 sg:pub.10.1023/a:1005792830054
23 sg:pub.10.1038/bjc.1990.58
24 https://app.dimensions.ai/details/publication/pub.1082997667
25 https://doi.org/10.1002/jbmr.5650091002
26 https://doi.org/10.1002/jbmr.5650101022
27 https://doi.org/10.1016/0140-6736(93)92555-8
28 https://doi.org/10.1016/s0015-0282(16)54948-6
29 https://doi.org/10.1016/s0015-0282(16)58200-4
30 https://doi.org/10.1016/s0959-8049(01)80148-9
31 https://doi.org/10.1016/s0959-8049(97)10036-3
32 https://doi.org/10.1016/s0959-8049(97)10135-6
33 https://doi.org/10.1056/nejm197602192940801
34 https://doi.org/10.1067/mgn.2001.113534
35 https://doi.org/10.1093/jnci/90.9.704
36 https://doi.org/10.1200/jco.1997.15.4.1341
37 https://doi.org/10.1200/jco.2000.18.14.2718
38 https://doi.org/10.1200/jco.2002.05.042
39 https://doi.org/10.1200/jco.2002.09.112
40 https://doi.org/10.1359/jbmr.1997.12.1.16
41 https://doi.org/10.3109/00016349609033310
42 https://doi.org/10.3109/07357909809039747
43 schema:datePublished 2003-12
44 schema:datePublishedReg 2003-12-01
45 schema:description The purpose of this study was to compare changes in bone mineral density (BMD) in premenopausal patients with node-positive early breast cancer treated with goserelin (Zoladex) or cyclophosphamide, methotrexate and 5-fluorouracil (CMF). Patients ( n=1640) were randomized to goserelin (3.6 mg every 28 days for 2 years) or CMF (sixx28-day cycles) treatment. In a protocoled sub-study involving 96 patients from eight centers (goserelin: n=53; CMF: n=43), lumbar spine (L2-L4) and femoral neck BMD were assessed by dual X-ray absorptiometry at baseline and then annually for 3 years. At the end of the 2-year goserelin-treatment period, mean BMD losses for goserelin-treated and CMF-treated patients were -10.5% and -6.5% ( P=0.0005) for lumbar spine and -6.4% and -4.5% ( P=0.04) for femoral neck, respectively. At 3 years, partial recovery of BMD was observed in goserelin recipients. In contrast, mean BMD losses for the CMF group indicated persistent BMD loss. No significant differences in BMD were observed between groups at the 3-year assessment of the spine or femoral neck. In the CMF group, based on amenorrhea status at 48 weeks, BMD losses at the lumbar spine were greater for amenorrheic than non-amenorrheic patients. Ovarian suppression resulting in amenorrhea was closely related to BMD loss in both treatment groups. Overall, patients who received CMF did not show recovery of BMD throughout follow-up, whereas partial recovery was observed 1 year after cessation of goserelin therapy, associated with the return of ovarian function in the majority of patients.
46 schema:genre research_article
47 schema:inLanguage en
48 schema:isAccessibleForFree false
49 schema:isPartOf N04742ab85b7b477293599d687504d319
50 N05a72515a2eb4f49a6b46b294e4cdfa7
51 sg:journal.1100834
52 schema:name Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF)
53 schema:pagination 1001-1006
54 schema:productId N3c54c72945834fed9f438d2f1e00f899
55 N96b82b506e22452095c871fb4c7b4cff
56 Nd330b444486946669d120bf10e44a1fe
57 Nf143cd7c2f924660a71db40e691172f9
58 Nfeb743e16c4c488c8237208265b80722
59 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044150768
60 https://doi.org/10.1007/s00198-003-1508-y
61 schema:sdDatePublished 2019-04-10T14:04
62 schema:sdLicense https://scigraph.springernature.com/explorer/license/
63 schema:sdPublisher N30ac6082c97943c994a6079edd304e0a
64 schema:url http://link.springer.com/10.1007/s00198-003-1508-y
65 sgo:license sg:explorer/license/
66 sgo:sdDataset articles
67 rdf:type schema:ScholarlyArticle
68 N04742ab85b7b477293599d687504d319 schema:issueNumber 12
69 rdf:type schema:PublicationIssue
70 N056dd29e4e5c480db554cf96f2efa8de rdf:first sg:person.0705212163.54
71 rdf:rest N116dd2119c9b4ff996028d982db51370
72 N05a72515a2eb4f49a6b46b294e4cdfa7 schema:volumeNumber 14
73 rdf:type schema:PublicationVolume
74 N09e77b26d1624861b40a9f0929a8bb9b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Amenorrhea
76 rdf:type schema:DefinedTerm
77 N0aa0c52c93df47ec99e241aacd4c3c8b rdf:first sg:person.0646232763.44
78 rdf:rest N1f310b96d99b4ac8bcaba2b6bbf6522e
79 N0b15d731040e4586bb10c351b35572c1 schema:affiliation Nd16883357c20413bab2948575823fab3
80 schema:familyName Serin
81 schema:givenName D.
82 rdf:type schema:Person
83 N116dd2119c9b4ff996028d982db51370 rdf:first sg:person.01026070224.70
84 rdf:rest N0aa0c52c93df47ec99e241aacd4c3c8b
85 N1289d3b6946044a8afabd0a9d7867e0e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Antineoplastic Combined Chemotherapy Protocols
87 rdf:type schema:DefinedTerm
88 N14ed988d10694259a1714c1d82067c86 schema:name Department of Nuclear Medicine, Guy’s, Kings and St Thomas’ Hospital Medical School, SE1 9RT, London, UK
89 rdf:type schema:Organization
90 N1f310b96d99b4ac8bcaba2b6bbf6522e rdf:first N0b15d731040e4586bb10c351b35572c1
91 rdf:rest N67c6c32fb31f4d5aa78d64d77af20950
92 N1f4d19be1fcc47e1a9f9daeafdae1459 rdf:first sg:person.0655217537.21
93 rdf:rest Nf9cffb288fd64b9790b9787fbb81f832
94 N1fd4c84b2c2d482c8d68cb9bc656dd76 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
95 schema:name Goserelin
96 rdf:type schema:DefinedTerm
97 N2d9e96aea80a4c0da1de561a59aca666 rdf:first sg:person.01021440563.37
98 rdf:rest rdf:nil
99 N30ac6082c97943c994a6079edd304e0a schema:name Springer Nature - SN SciGraph project
100 rdf:type schema:Organization
101 N34977b6ec606481da6485f552ec1a411 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Bone Density
103 rdf:type schema:DefinedTerm
104 N357510f285774d9696d2c25ba394191e schema:name Institute fur Medizinische Biometrie und Informatik, University Hospital, Freiburg, Germany
105 rdf:type schema:Organization
106 N3c54c72945834fed9f438d2f1e00f899 schema:name readcube_id
107 schema:value d24e03ee1a1b3acf8c4c49d9c883c9a523b10d2e69a61c23255507aee2ebe21e
108 rdf:type schema:PropertyValue
109 N45f476f744164f41978045d506928a99 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Femur Neck
111 rdf:type schema:DefinedTerm
112 N487ae48d94be409aa81e80bb5f51c623 rdf:first sg:person.015650304144.58
113 rdf:rest N056dd29e4e5c480db554cf96f2efa8de
114 N61e257e5026b46c49b493335d043fd10 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
115 schema:name Humans
116 rdf:type schema:DefinedTerm
117 N67c6c32fb31f4d5aa78d64d77af20950 rdf:first sg:person.0647367524.01
118 rdf:rest N2d9e96aea80a4c0da1de561a59aca666
119 N729f1bf2afdc4a17ac56b8288129a35e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Fluorouracil
121 rdf:type schema:DefinedTerm
122 N79406c9bef7a4c6aa078a89f9262bc8f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Lumbar Vertebrae
124 rdf:type schema:DefinedTerm
125 N8d88a87411f94434976c6fc1773e4ed9 schema:name Department of Nuclear Medicine, Guy’s, Kings and St Thomas’ Hospital Medical School, SE1 9RT, London, UK
126 rdf:type schema:Organization
127 N96b82b506e22452095c871fb4c7b4cff schema:name nlm_unique_id
128 schema:value 9100105
129 rdf:type schema:PropertyValue
130 Na8e95a1886684a459294b0d7c7da4731 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Methotrexate
132 rdf:type schema:DefinedTerm
133 Nba0b915563df43a3ac5aad042c061d84 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Premenopause
135 rdf:type schema:DefinedTerm
136 Nc9b11d36ca584e8bac95b86d3dbc4c04 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Adult
138 rdf:type schema:DefinedTerm
139 Nd0f6bc6dd948477a801e9a5f28ebec7c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Female
141 rdf:type schema:DefinedTerm
142 Nd16883357c20413bab2948575823fab3 schema:name Clinic Sainte Catherine, Avignon, France
143 rdf:type schema:Organization
144 Nd330b444486946669d120bf10e44a1fe schema:name doi
145 schema:value 10.1007/s00198-003-1508-y
146 rdf:type schema:PropertyValue
147 Nda8e7a1db26341149022da9d19da6925 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Breast Neoplasms
149 rdf:type schema:DefinedTerm
150 Ndfed191195a240c6a2312a9fd60117ac schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Cyclophosphamide
152 rdf:type schema:DefinedTerm
153 Ne4baf7b9a965484c80d101effdf7c85a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Antineoplastic Agents, Hormonal
155 rdf:type schema:DefinedTerm
156 Ne66810de7ea44221bfed6b5e201b9c9d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
157 schema:name Drug Administration Schedule
158 rdf:type schema:DefinedTerm
159 Nf143cd7c2f924660a71db40e691172f9 schema:name dimensions_id
160 schema:value pub.1044150768
161 rdf:type schema:PropertyValue
162 Nf56362ad82ca4219ac267a6cd615b402 schema:name Nottingham Hospital, Nottingham, UK
163 rdf:type schema:Organization
164 Nf9cffb288fd64b9790b9787fbb81f832 rdf:first sg:person.01102033437.11
165 rdf:rest N487ae48d94be409aa81e80bb5f51c623
166 Nfeb743e16c4c488c8237208265b80722 schema:name pubmed_id
167 schema:value 14530912
168 rdf:type schema:PropertyValue
169 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
170 schema:name Medical and Health Sciences
171 rdf:type schema:DefinedTerm
172 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
173 schema:name Clinical Sciences
174 rdf:type schema:DefinedTerm
175 sg:journal.1100834 schema:issn 0937-941X
176 1433-2965
177 schema:name Osteoporosis International
178 rdf:type schema:Periodical
179 sg:person.01021440563.37 schema:affiliation https://www.grid.ac/institutes/grid.417815.e
180 schema:familyName Wilpshaar
181 schema:givenName W.
182 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01021440563.37
183 rdf:type schema:Person
184 sg:person.01026070224.70 schema:familyName Sauerbrei
185 schema:givenName W.
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026070224.70
187 rdf:type schema:Person
188 sg:person.01102033437.11 schema:affiliation N8d88a87411f94434976c6fc1773e4ed9
189 schema:familyName Blake
190 schema:givenName G. M.
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01102033437.11
192 rdf:type schema:Person
193 sg:person.015650304144.58 schema:affiliation Nf56362ad82ca4219ac267a6cd615b402
194 schema:familyName Blamey
195 schema:givenName R.
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015650304144.58
197 rdf:type schema:Person
198 sg:person.0646232763.44 schema:affiliation N357510f285774d9696d2c25ba394191e
199 schema:familyName Schumacher
200 schema:givenName M.
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0646232763.44
202 rdf:type schema:Person
203 sg:person.0647367524.01 schema:affiliation https://www.grid.ac/institutes/grid.415720.5
204 schema:familyName Stewart
205 schema:givenName A.
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0647367524.01
207 rdf:type schema:Person
208 sg:person.0655217537.21 schema:affiliation N14ed988d10694259a1714c1d82067c86
209 schema:familyName Fogelman
210 schema:givenName I.
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0655217537.21
212 rdf:type schema:Person
213 sg:person.0705212163.54 schema:affiliation https://www.grid.ac/institutes/grid.417815.e
214 schema:familyName Palmer
215 schema:givenName M.
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0705212163.54
217 rdf:type schema:Person
218 sg:pub.10.1007/bf02555894 schema:sameAs https://app.dimensions.ai/details/publication/pub.1020486492
219 https://doi.org/10.1007/bf02555894
220 rdf:type schema:CreativeWork
221 sg:pub.10.1007/s001980070062 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012689352
222 https://doi.org/10.1007/s001980070062
223 rdf:type schema:CreativeWork
224 sg:pub.10.1023/a:1005792830054 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003671030
225 https://doi.org/10.1023/a:1005792830054
226 rdf:type schema:CreativeWork
227 sg:pub.10.1038/bjc.1990.58 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015146238
228 https://doi.org/10.1038/bjc.1990.58
229 rdf:type schema:CreativeWork
230 https://app.dimensions.ai/details/publication/pub.1082997667 schema:CreativeWork
231 https://doi.org/10.1002/jbmr.5650091002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017261313
232 rdf:type schema:CreativeWork
233 https://doi.org/10.1002/jbmr.5650101022 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053074833
234 rdf:type schema:CreativeWork
235 https://doi.org/10.1016/0140-6736(93)92555-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027878716
236 rdf:type schema:CreativeWork
237 https://doi.org/10.1016/s0015-0282(16)54948-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037961107
238 rdf:type schema:CreativeWork
239 https://doi.org/10.1016/s0015-0282(16)58200-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007157689
240 rdf:type schema:CreativeWork
241 https://doi.org/10.1016/s0959-8049(01)80148-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006522013
242 rdf:type schema:CreativeWork
243 https://doi.org/10.1016/s0959-8049(97)10036-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019758885
244 rdf:type schema:CreativeWork
245 https://doi.org/10.1016/s0959-8049(97)10135-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012452075
246 rdf:type schema:CreativeWork
247 https://doi.org/10.1056/nejm197602192940801 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022455515
248 rdf:type schema:CreativeWork
249 https://doi.org/10.1067/mgn.2001.113534 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005950645
250 rdf:type schema:CreativeWork
251 https://doi.org/10.1093/jnci/90.9.704 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018904729
252 rdf:type schema:CreativeWork
253 https://doi.org/10.1200/jco.1997.15.4.1341 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083105853
254 rdf:type schema:CreativeWork
255 https://doi.org/10.1200/jco.2000.18.14.2718 schema:sameAs https://app.dimensions.ai/details/publication/pub.1074667563
256 rdf:type schema:CreativeWork
257 https://doi.org/10.1200/jco.2002.05.042 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064202982
258 rdf:type schema:CreativeWork
259 https://doi.org/10.1200/jco.2002.09.112 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064203132
260 rdf:type schema:CreativeWork
261 https://doi.org/10.1359/jbmr.1997.12.1.16 schema:sameAs https://app.dimensions.ai/details/publication/pub.1021846486
262 rdf:type schema:CreativeWork
263 https://doi.org/10.3109/00016349609033310 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032765154
264 rdf:type schema:CreativeWork
265 https://doi.org/10.3109/07357909809039747 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019046058
266 rdf:type schema:CreativeWork
267 https://www.grid.ac/institutes/grid.415720.5 schema:alternateName The Christie Hospital
268 schema:name Christie Hospital, Manchester, UK
269 rdf:type schema:Organization
270 https://www.grid.ac/institutes/grid.417815.e schema:alternateName AstraZeneca (United Kingdom)
271 schema:name AstraZeneca, Macclesfield, UK
272 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...